Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201106039 Principal Investigator: Uy, Geoffrey
Title: Chemosensitization with Plerixafor Plus G-CSF in Relapsed or Refractory Acute Myeloid Leukemia
Phase: I/II Disease Site: Myeloid and Monocytic Leukemia
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of the first phase of the study is to learn what dose of an investigational drug, plerixafor along with G-CSF can be safely given with standard of care chemotherapy drugs.

Once the first phase of the study is completed, the second phase of the study will determine whether the combination of plerixafor + G-CSF with Mitoxantrone, Etoposide and Cytarabine (MEC) can be more effective in treating leukemia than (MEC) alone.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)